Advertisement

Topics

Simulations Plus Releases MembranePlus™ Version 2

08:30 EDT 23 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Major update incorporates new models and tighter integration with GastroPlus™ Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, chemicals, and consumer ...

Other Sources for this Article

Simulations Plus Investor Relations
Ms. Renee Bouche, 661-723-7723
renee@simulations-plus.com
or
Hayden IR
Mr. Cameron Donahue, 651-653-1854
cameron@haydenir.com

NEXT ARTICLE

More From BioPortfolio on "Simulations Plus Releases MembranePlus™ Version 2"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...